| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |